OM202JP Clinical Study of KNP2002

PHASE2CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

July 27, 2024

Study Completion Date

July 27, 2024

Conditions
Common Wart
Interventions
DRUG

KNP2002

Dairy topical administration for 12 weeks

DRUG

Placebo of KNP2002

Dairy topical administration for 12 weeks

Trial Locations (15)

371-0046

Kawaharamachi Dermatology, Maebashi

672-8084

Tetsuya Dermatology, Himeji

657-0027

Takashima Dermatology, Kobe

657-0065

Nishino Dermatology Clinic, Kobe

220-6208

Queen's Square, Dermatology, Allergy, Yokohama

240-0013

Asai Dermatology Clinic, Yokohama

593-8301

Okawa Dermatology Clinic, Sakai

321-2471

Sugai Dermatology Parkside Clinic, Utsunomiya

116-0003

Tsunoda Clinic, Arakawa-Ku

125-0041

Sugisawa Dermatology Clinic, Katsushika-ku

115-0045

Igarashi Clinic, Kita-ku

136-0074

Maruyama Dermatology Clinic, Koto-Ku

164-0001

Todoroki Dermatology Clinic, Nakano-Ku

157-0062

Okuda Dermatology Clinic, Setagaya-Ku

537-0013

Hayami Dermatology, Osaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

KinoPharma Inc.

INDUSTRY

NCT05896215 - OM202JP Clinical Study of KNP2002 | Biotech Hunter | Biotech Hunter